Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals.
about
Maraviroc: a review of its use in HIV infection and beyondFull Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo Studies.Temporary CXCR3 and CCR5 antagonism following vaccination enhances memory CD8 T cell immune responsesPreclinical discovery and development of maraviroc for the treatment of HIV.
P2860
Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of maraviroc intensific ...... ly HIV-1-infected individuals.
@en
Effect of maraviroc intensific ...... ly HIV-1-infected individuals.
@nl
type
label
Effect of maraviroc intensific ...... ly HIV-1-infected individuals.
@en
Effect of maraviroc intensific ...... ly HIV-1-infected individuals.
@nl
prefLabel
Effect of maraviroc intensific ...... ly HIV-1-infected individuals.
@en
Effect of maraviroc intensific ...... ly HIV-1-infected individuals.
@nl
P2093
P2860
P50
P1433
P1476
Effect of maraviroc intensific ...... ly HIV-1-infected individuals.
@en
P2093
Ai Kawana-Tachikawa
Aikichi Iwamoto
Anton L Pozniak
Christian Manzardo
Isabel Bravo
Jordi Puig
Jose M Gatell
Jose M Miro
Josep M Llibre
Julia Blanco
P2860
P304
P356
10.1371/JOURNAL.PONE.0087334
P407
P577
2014-01-27T00:00:00Z